User-Generated Data Brings Revenue: It’s Time for the Users to Get Some

In this op-ed, Dr. Roggen et al. propose a system for websites like Leafly that would allow its users to share revenue from their content and personal data, enabling a higher sense of trust, credibility and ultimately more value for every stakeholder involved. Using NFTs, they suggest consumers in the cannabis industry could generate a product and benefit from it too.

The post User-Generated Data Brings Revenue: It’s Time for the Users to Get Some appeared first on Cannabis Industry Journal.

Craft Beer & Cannabis: Oskar Blues Founder Joins Veritas Fine Cannabis

Dale Katechis introduced the world to canned craft beer back in 2002. As the founder of Oskar Blues, he led the company and the country down a new path for independent craft brewers. In this piece, we sit down with Dale Katechis to learn about his new foray into cannabis and drink a few of his namesake beers, Dale’s Pale Ale.

The post Craft Beer & Cannabis: Oskar Blues Founder Joins Veritas Fine Cannabis appeared first on Cannabis Industry Journal.

European Cannabis is Starting to Look Like the US Market 10 Years Ago

While still a very immature market, Europe will follow its own path by acknowledging the failures and successes of other markets, blending them to form its own unique European model.

The post European Cannabis is Starting to Look Like the US Market 10 Years Ago appeared first on Cannabis Industry Journal.

Jazz Pharmaceuticals to Acquire GW Pharma

In a press release published last week, the two companies announced they have entered an agreement for Jazz to acquire GW Pharma, the producer of the only FDA-approved CBD medication Epidiolex, for a total of $7.2 billion.

The post Jazz Pharmaceuticals to Acquire GW Pharma appeared first on Cannabis Industry Journal.